According to a recent FCC filling, Alphabet’s Life Sciences wing Verily has recently developed a new “Connectivity Bridge” for use in clinical studies. The device is capable of collecting and syncing medical information of people participating in clinical studies, allowing Google to continue to improve its efforts in healthcare.
The filing, first discovered by Business Insider, shows a small prism device designed to act as a wireless hub that can be installed in medical facilities or in patient homes to automatically collect data from various sensors and upload the information to the cloud for instant analysis.
For instance, Verily is currently handling the tracking of data and data analysis in a multiple sclerosis study at Brigham and Women’s Hospital in Boston. Participants in the study could use the Connectivity Bridge to submit data to their doctors as soon as it is collected. Participants are using a suite of apps called Study Kit to analyze and track data.
Last year, Alphabet showed off a Verily device that was used to track information from patients going through clinical trials. The wristband can measure factors such as pulse, skin temperature, and external variants like noise. At the time, Google also said it was working to develop better software for researchers to use to store, analyze, and interpret data from its products. It’s likely that the Connectivity Bridge plays a role in that software, combining data from a variety of sources and making a central location for researchers to view and analyze it.
Alphabet has been investing heavily in its life science and health branches recently, putting more than $2.4 billion into 39 companies as of December. With the company developing hardware, as well, it seems incredibly committed to its efforts.
FTC: We use income earning auto affiliate links. More.